113 related articles for article (PubMed ID: 32470878)
1. Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133.
Zhang W; Chai W; Zhu Z; Li X
Int Immunopharmacol; 2020 Aug; 85():106618. PubMed ID: 32470878
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation-Mediated Lowly Expressed AOX1 Promotes Cell Migration and Invasion of Prostate Cancer.
Wu J; Wei Y; Li T; Lin L; Yang Z; Ye L
Urol Int; 2023; 107(5):517-525. PubMed ID: 35354150
[TBL] [Abstract][Full Text] [Related]
4. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.
Yuan Z; Liang X; Zhan Y; Wang Z; Xu J; Qiu Y; Wang J; Cao Y; Le VM; Ly HT; Xu J; Li W; Yin P; Xu K
Br J Cancer; 2020 Apr; 122(9):1342-1353. PubMed ID: 32203206
[TBL] [Abstract][Full Text] [Related]
5. ROS-generating oxidase NOX1 promotes the self-renewal activity of CD133+ thyroid cancer cells through activation of the Akt signaling.
Wang C; Wang Z; Liu W; Ai Z
Cancer Lett; 2019 Apr; 447():154-163. PubMed ID: 30690057
[TBL] [Abstract][Full Text] [Related]
6. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
[TBL] [Abstract][Full Text] [Related]
9. 470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
Mo S; Ku HJ; Choi SH; Jeong HJ; Park DG; Oh MH; Ahn JC
Anticancer Res; 2021 Mar; 41(3):1407-1420. PubMed ID: 33788732
[TBL] [Abstract][Full Text] [Related]
10. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis.
Kazama S; Kishikawa J; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Watanabe T
Asian J Surg; 2018 May; 41(3):274-278. PubMed ID: 28190751
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
12. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
13. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells.
Huang WS; Huang CY; Hsieh MC; Kuo YH; Tung SY; Shen CH; Hsieh YY; Teng CC; Lee KC; Lee KF; Kuo HC
Cell Physiol Biochem; 2018; 51(6):2616-2630. PubMed ID: 30562740
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
15. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde oxidase 1 gene is regulated by Nrf2 pathway.
Maeda K; Ohno T; Igarashi S; Yoshimura T; Yamashiro K; Sakai M
Gene; 2012 Sep; 505(2):374-8. PubMed ID: 22705828
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.
Weng CC; Kuo KK; Su HT; Hsiao PJ; Chen YW; Wu DC; Hung WC; Cheng KH
Pancreas; 2016 Mar; 45(3):443-57. PubMed ID: 26646272
[TBL] [Abstract][Full Text] [Related]
19. Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.
Akbari M; Shanehbandi D; Asadi M; Shomali N; Faraji A; Khaze V; Pakdel A; Mokhtarzadeh A; Ebrahimi AA; Shabani A; Bardaran B
Iran J Immunol; 2019 Sep; 16(3):246-257. PubMed ID: 31552833
[TBL] [Abstract][Full Text] [Related]
20. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
